APRIL : 2016 results Implementation of growth levers Stable

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
57
APRIL : 2016 results Implementation of growth levers Stable current EBIT targeted for 2017

Lyon, 8 March 2017

APRIL: 2016 results

Implementation of growth levers

Stable current EBIT targeted for 2017

  • Sales up 7.9%, reflecting the return to growth in our brokerage business
  • Current EBIT of €65.4m, in line with expectations
  • Net income of €20.1m, impacted by the reorganisation of international operations
  • Solid financial structure, with €188.9m in adjusted net cash at 31 December
  • Proposed dividend of €0.26 per share, a sign of confidence in the Group's outlook

APRIL CEO Emmanuel Morandini made the following comments: "The results for 2016 show that we are moving in the right direction: we posted strong sales momentum in our brokerage business, including in the health insurance market, and the impacts of the National Interbranch Agreement (ANI) are now largely behind us. In accordance with its core values, the Group will continue to serve customers through segmentation, innovation and digitised relationship management. At the same time, APRIL will continue to invest in initiatives aimed at streamlining and automating processes, achieving productivity gains and optimising cost structures. The Group confirms its commitment to reducing loss-making operations, by reorganising or withdrawing from certain countries, if necessary. Finally, we will strive to expand our expertise into selected countries, including through targeted acquisitions. The transformation initiatives implemented over the last eighteen months are now bearing fruit. We are confident in the Group's ability to stabilise its results in 2017, before gradually improving its financial performance."

Group (IFRS - €m) 2016 2015 Change
Consolidated sales 861.2 798.0 +7.9%
Gross margin 1 420.6 409.4 +2.7%
Financial income 16.4 15.4 +6.6%
Current EBIT 65.4 73.1 -10.6%
EBIT 42.1 71.3 -40.9%
Net income (Group share) 20.1 42.1 -52.3%
Dividend per share (€) 0.26 0.26 -
Group (IFRS - €m) 2016 2015 Change
Shareholders' equity (Group share) 614.5 605.7 +1.5%
Financial debt % of shareholders' equity 6.5 1.06% 2.8 0.46% +134.0%
Adjusted net cash [2] 188.9 193.2 -2.2%

The Board of Directors met on 8 March 2017 to approve APRIL's statutory and consolidated financial statements. The statutory auditors are currently completing their certification of the financial statements.

Group

APRIL posted 2016 consolidated sales of €861.2m, up 7.9% from 2015 as reported and up 7.4% like-for-like [3] . Like-for-like sales exclude the impact of a -€3.6m exchange rate fluctuation and a €7.4m consolidation gain. Insurance premiums increased 15.7% like-for-like to €375.4m. Brokerage commissions amounted to €485.8m, up 1.8% like-for-like, reflecting growth in Property & Casualty (up 3.7%) and Health & Personal Protection (up 0.6%).

Health & Personal Protection posted sales up 4.3% as reported and up 3.0% like-for-like. Property & Casualty stepped up its growth, with sales up 14.0 % as reported and up 15.0% like-for-like.

Thanks to strong sales momentum, the gross margin rose 2.7% to €420.6m, up €6.5m to €359.4m in brokerage and up €4.7m to €61.2m in our risk-carrying business. Underlying sales momentum was positive for both divisions (Health & Personal Protection and Property & Casualty).

Net financial income amounted to €16.4m, up €1.0m. This includes €3.3m in capital gains on the sale of financial assets and €0.1m in currency gains, compared with €0.8m and €1.1m respectively in 2015. Adjusted for these items, net financial income would come to €13.0m, down €0.5m, marked by prolonged low interest rates that impacted the Group's return on cash and financial assets.

Current EBIT amounted to €65.4m, down 10.6% compared to 2015, in line with forecasts announced during the year. It was marked by the negative impact on the Group's individual health insurance business of the extension of group private health insurance. The Group also continued its investments aimed at supporting sales momentum and better meeting customer expectations, as well as its ongoing initiatives to optimise its cost structure.

Non-current operating expenses amounted to €23.3m, slightly above expectations. As previously announced, they mostly result from the late 2016 reorganisation of the Group's operations in the United States and Switzerland (-€16.5m). As a reminder, the majority of these expenses comes from taking intangible assets to profit and loss account and therefore had no impact on Group cash. EBIT thus amounted to €42.1m, down €29.2m.

After a tax charge of €22.2m, consolidated net income (Group share) amounted to €20.1m, versus €42.1m in 2015.

Health & Personal Protection

Health & Personal Protection (IFRS - €m) 2016 2015 Change  
Consolidated sales 527.7 505.7 +4.3% +3.0% LFL 3  
Gross margin 260.3 256.4 +1.5%  
Financial income 11.5 11.1 +3.5%  
Current EBIT 71.9 77.3 -6.9%  

The Health & Personal Protection division reported a 4.3% increase in sales comprising a 2.7% increase in brokerage commissions as reported (up 0.6% like-for-like) and a 6.8% increase in premiums.

The increase in insurance premiums was driven by growth in the individual (seniors and self-employed) and expatriate Health & Personal Protection portfolios. It also reflects the growth in group private health insurance portfolios generated by partnerships set up to meet the demand created by the extension of group private health insurance.

The increase in brokerage commissions mainly stems from strong performances in loan, group health and personal protection insurance, which helped offset the expected decline in our individual employee health insurance portfolios.

The Health & Personal Protection gross margin increased 1.5% to €260.3m, mainly due to the division's integration of GlobalHealth and Bamado, the impact of which was partially offset by the decline in individual employee health insurance portfolios.

The division's current EBIT amounted to €71.9m, down 6.9% compared to the previous year. This decline is attributable to changes in the health insurance market, as well as investments made in order to streamline our organisation, sustain growth momentum and optimise policy and claims handling.

Property & Casualty

Property & Casualty (IFRS - €m) 2016 2015 Change  
Consolidated sales 336.0 294.8 +14.0% +15.0% LFL 3  
Gross margin 160.3 153.0 +4.7%  
Financial income 4.0 3.6 +12.8%  
Current EBIT 4.6 5.7 -18.6%  

In the Property & Casualty division, the strong growth in premiums was driven by the expansion of the legal protection business and by corporate and affinity member operations, strongly protected by reinsurance arrangements.

Commissions , which posted like-for-like growth for the second year in a row, were fueled by the expansion of wholesale brokerage, specifically in motor insurance, two-wheeled vehicle insurance and the professional range. The APRIL Mon Assurance agency network posted portfolio growth, particularly in P&C, and continued to implement action plans to enhance customer loyalty. In addition, despite a challenging macro-economic environment in some countries, travel insurance sales increased slightly, particularly in the US and Latin America.

The increase in the gross margin was mainly driven by strong performances in P&C wholesale brokerage in France.

The Property & Casualty division posted current EBIT of €4.6m, down from €5.7m in 2015, impacted by investments made to drive growth momentum and optimise policy and claims handling, as well as a lower performance in Latin America that triggered the restructuring undergone at the end of the year.

Financial position

At 31 December 2016, APRIL showed a healthy financial structure:

  • €614.5m in consolidated shareholders' equity (Group share), up €8.8m over 2015,
  • Financial debt of €6.5m, i.e. 1.1% of shareholders' equity (Group share), mainly comprising commitments made as part of the Group's acquisition policy (earnouts and commitments to buy back minority interests),
  • Group net cash , adjusted for deposit accounts held in relation to the Company's cash management policy, amounted to €188.9m, versus €193.2m in 2015.

Dividend

For 2016, a dividend of €0.26 per share will be proposed by the Group at the Annual General Meeting, representing a total of €10.6m, identical to that of 2015. This divergence from APRIL's dividend payout policy reflects the Group's desire to offset the impact of non-current non-cash expenses, which weighed heavily on 2016 net income. It also bears witness to the Group's confidence in its short and medium-term outlook.

Challenges and outlook

Thanks to the actions carried out in 2015 and 2016 and which will continue this year, the Group aims to stabilise its current EBIT in 2017.

"More than ever, our teams are fully committed to the four growth levers (brokerage, partnerships and key accounts, digitalisation and direct distribution, international) and the underlying theme is to focus all our actions on our clients, in order to make insurance easier for them. The Group will continue to draw on its ability to innovate and develop client-inspired products, its renowned policy and claims handling, its hyper segmented approach allowing for tailored offers, its teams of specialists who care about building close relationships and trust with all of our clients. The decentralised organisation of the Group allows for flexibility and agility, which are key advantages in our ever-changing world. All those advantages shall bring APRIL back to sustainable growth" Bruno Rousset, APRIL Chairman, stated.

Upcoming releases:

  • 2016 Annual results presentation: 9 March 2017 at 9.30 am in Paris
  • Q1 2017 sales: 25 April 2017 after market close
  • Shareholder Annual General Meeting: 4 May 2017, in Lyon

This release contains forward-looking statements that are based on assessments or assumptions that were reasonable at the date of the release, and which may change or be altered due to, in particular, random events or uncertainties and risks relating to the economic, financial, regulatory and competitive environment, the risks set out in the 2015 Registration Document, and any risks that are unknown or non-material to date that may subsequently occur. The Company undertakes to publish or disclose any adjustments or updates to this information as part of the periodical and permanent information obligation to which all listed companies are subject.

The 2016 results presentation will be audiocast live in French on Thursday 9 March at 9.30am on www.april.com and a replay will be available from 2pm on the same day. 

Contacts:

Analysts and investors Guillaume Cerezo: +33 (0)4 72 36 49 31 / +33 (0)6 20 26 06 24 - guillaume.cerezo@april.com

Press Samantha Druon: +33(0)4 72 00 46 56 - samantha.druon@insign.fr

About APRIL

Established in 1988, APRIL is an international insurance services group with operations based in 31 countries in Europe, America, Asia, Africa and the Middle East, and the leading wholesale broker in France. Listed on Euronext Paris (Compartment B), the Group posted sales of €861m in 2016. Its 3,860 staff members design, manage and distribute specialist insurance solutions (health and personal protection, property and casualty, mobility and legal protection) as well as assistance services, for private individuals, professionals and businesses, by pursuing the ambition APRIL set itself from the very beginning: to change the image of insurance and make it easier and more accessible. Driven by a strong entrepreneurial culture, the group bases its development on four values in support of its customers: building trust, pushing boundaries, innovating and keeping things simple.

Full regulated information is available on our website at www.april.com (Investors section).

Appendix 1: Summary consolidated income statement

(IFRS - €m) 2016 2015
Sales 861.2 798.0
Net financial income (excluding financing cost) 16.4 15.4
Total income from ordinary activities 877.6 813.4
Insurance underwriting expenses (302.8) (255.1)
Income or expenses net of ceded reinsurance (24.9) (24.7)
Other purchases and external expenses (110.9) (105.3)
Retrocession of commissions (126.3) (120.9)
Tax (24.5) (24.5)
Staff costs (201.0) (190.4)
Depreciation allowance (17.3) (15.4)
Provisions (net of reversals) (2.8) (0.5)
Other current operating income and expenses (1.6) (3.5)
Current EBIT 65.4 73.1
Changes in goodwill - (1.6)
Non-current income and expenses (23.2) (0.2)
EBIT 42.1 71.3
Financing cost (0.0) (0.0)
Share of companies integrated on an equity basis (0.1) (0.1)
Corporate income tax (22.2) (29.1)
Net income from continuing operations 19.8 42.1
Net income/(loss) from discontinued operations after tax (0.0) (0.0)
Consolidated net income 19.8 42.1
Minority interests (0.3) 0.0
Net income (Group share) 20.1 42.1
Earnings per share (in €) 0.50 1.04

Appendix 2: Summary consolidated balance sheet

(IFRS - €m) 31 December 2016 31 December 2015
Intangible assets 281.6 278.5
Goodwill 217.0 220.1
Tangible assets 11.5 12.1
Financial investments 655.2 655.6
Reinsurers' share of underwriting provisions and financial liabilities 215.0 206.9
Other non-current assets 23.3 24.0
Total non-current assets 1,186.6 1,177.1
Receivables from insurance and accepted reinsurance operations 96.8 79.1
Receivables from ceded reinsurance operations 42.1 63.5
Trade receivables 226.7 199.2
Cash and cash equivalents 99.5 101.8
Other current assets 40.8 40.6
Total current assets 505.8 484.1
TOTAL ASSETS 1,692.5 1,661.2
Shareholders' equity (Group share) 614.5 605.7
Minority interests 0.3 0.9
Total shareholders' equity 614.8 606.6
Underwriting provisions for insurance policies 478.3 475.8
Provisions for contingencies and charges 29.9 26.9
Deferred tax liabilities 7.0 9.7
Financial debt 6.5 2.8
Total non-current liabilities 521.7 515.2
Current bank loans and overdrafts 11.5 18.4
Payables from insurance and accepted reinsurance operations 46.7 43.1
Payables from ceded reinsurance operations 79.9 101.3
Operating liabilities 301.9 268.2
Other current liabilities 115.9 108.5
Total current liabilities 555.9 539.5
TOTAL EQUITY AND LIABILITIES 1,692.5 1,661.2

Appendix 3: Summary consolidated cash flow statement

(IFRS - €m) 2016 2015
Net income (Group share) 20.1 42.1
Net income/(loss) from discontinued operations (0.0) (0.0)
Minority interest in consolidated companies' net income (0.3) 0.0
Net income from continuing operations 19.8 42.1
Cash flow 44.0 24.5
Change in operating working capital (3.9) 7.6
Operating cash flow from discontinued operations (0.0) 0.0
Net cash flow from operating activities 40.1 32.1
Net investment in tangible and intangible assets (22.4) (25.2)
Net investment in financial assets 2.3 27.9
Net cash flow from acquisition/disposal of consolidated companies (4.1) (3.3)
Investment in equity-accounted companies - (0.2)
Investment cash flow from discontinued operations - -
Net cash flow from investing activities (24.2) (0.8)
Capital increase linked to exercise of stock options - -
Capital increase linked to minority interests in consolidated companies 0.1 0.0
Purchase and sale of own shares 0.0 0.1
Dividends paid out (10.9) (17.7)
Net change in borrowings (0.3) (0.1)
Financing cash flow from discontinued operations - -
Net cash flow from financing activities (11.1) (17.7)
Impact of foreign exchange rates changes (0.3) 0.1
Change in net cash and cash equivalents 4.5 13.8

1 Gross margin allows a comparison between the various brokerage business models and the insurance businesses and shows the contribution of each business to Group value-added: -              With regard to brokerage, gross margin is the difference between (i) commissions recognised under sales and (ii) commissions paid to intermediaries recognised under purchases and external expenses. -              With regard to risk carrying operations, gross margin is the sum of the underwriting result and the financial result. [2] Adjusted net cash = Cash and cash equivalents - current bank loans and overdrafts + deposit accounts registered in the name of APRIL (classified under "Financial investments" on the balance sheet)

[3] Proforma or like-for-like sales, at constant exchange rates and consolidation scope, adjusted for acquisitions, disposals and changes in consolidation method, as well as exchange rate fluctuations, calculated on the basis of the prior year financial statements converted using the exchange rate for the current year.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...8e20df3d0a

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Betterness Expands Health Networks with $3.5M Boost

Updated Category News Views 65

Defining a Health Revolution in the Heart of Miami Just when you think the fitness tech scene might be settling into its groove, along comes Betterness, Inc., shaking things up with another cool million in their pockets. I'm talking about their recent addition to their seed round, now sitting pretty at a robust $3.5 million. You can't ignore how they're taking a...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 112

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 170

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Black Bayou Kicks Off Major Gas Storage Build in Louisiana

Updated Category News Views 140

Breaking Ground on a Massive Energy Undertaking Well, folks, Black Bayou's finally breaking ground on their colossal gas storage project in Cameron Parish, Louisiana. They're not just playing around—this thing's set to be a juggernaut, with an imposing 44.4 Bcf of working gas capacity nestled right on top of the Black Bayou salt dome. Talk about marking territory, huh?...

Continue Reading
LEOTEK's AI Tech Shaping Smarter Cities at COP31

Updated Category News Views 103

AI-Powered Evolution in Urban Infrastructure Hang on to your hats, folks, 'cause LEOTEK is turning heads at COP31 with its AI-driven transformation of urban landscapes. As cities stretch at the seams to keep up with modern challenges, LEOTEK's got more than a few tricks up its sleeve with its trademark blend of traffic system intelligence and energy management prowess....

Continue Reading
Dyania, NVIDIA Team Up: AI Transforming Patient Care

Updated Category News Views 61

Revving up efficiency in healthcare usually sounds like pie-in-the-sky talk, but every now and again, an innovation comes along that really stirs the pot. Enter Dyania Health's Synapsis AI, a clinical reasoning AI, teaming with NVIDIA's robust computing infrastructure. They're setting out to make sense of massive amounts of patient data, securely tucked behind a...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 131

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
JardogsHealth Taps Industry Titans for Growth Council

Updated Category News Views 181

JardogsHealth: A New Chapter with Strategic Insights You've got to admire when a company rounds up a top-tier brain trust. Such is the case with JardogsHealth, the healthcare AI outfit nestled in Hillsboro, Illinois, as they align their future alongside heavyweights who’ve maneuvered through multiple industries and come out thriving. Their brand-new council includes...

Continue Reading
Data Center Transformers on the Brink of a Boom

Updated Category News Views 305

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

Continue Reading
Emergency Strobe Light Device Eyes Market Potential

Updated Category News Views 34

An Idea Sparked in San Marcos This ain't your typical cocktail party chat. We're diving into a story born from necessity—where someone's trying to shave seconds off a life-or-death situation. From the busy streets of San Marcos, California, an inventor has brought a practical gem to the table: the LIFE STROBE. This gizmo is not just a bulb with a new flash pattern. It's...

Continue Reading

Top 5 Most Recently Viewed Articles

Miki Rai Teams Up With Mondays Made for Exclusive Jewelry Line

Updated Category News Views 338

Introducing the 'Rise & Shine' Jewelry Collection An 11-piece collection designed to inspire individuals to shine from within and remember their worth, the 'Rise & Shine' collection features unique jewelry pieces that blend elegance with modern style. Collaboration Between Iconic Brand and Influencer Mondays Made, recognized for its commitment to timeless designs and...

Continue Reading
ARS Pharma Showcases Real-World Effectiveness of Neffy

Updated Category News Views 193

ARS Pharma Presents Real-World Efficacy of Neffy® at ACAAI Meeting ARS Pharmaceuticals, Inc. (Nasdaq: SPRY) is set to unveil significant findings at the upcoming annual meeting of the American College of Allergy, Asthma & Immunology (ACAAI). With a strong commitment towards enhancing patient care in cases of anaphylaxis, ARS Pharma will present a late-breaking oral...

Continue Reading
Maximizing Monthly Income Through Nvidia Stock Investments

Updated Category News Views 107

Understanding Nvidia's Dividend Potential NVIDIA Corporation (NASDAQ: NVDA) has recently been generating buzz among investors, especially in the digital market. This increased attention has led many to consider how they can turn their stock investments into regular monthly income. Recent Performance Overview In the most recent trading days, Nvidia shares have shown...

Continue Reading
Nikkei 225 Rises as Key Sectors Drive Japan's Market Gains

Updated Category News Views 274

Market Overview of Japan's Nikkei 225 Performance The Japanese stock market witnessed positive movements with the Nikkei 225 index appreciating by 0.32% at the close of trading. This rise indicates a bullish sentiment among investors, primarily driven by key sectors including banking, services, and electrical machinery, which are vital components of Japan's economy. Top...

Continue Reading
Unisys Corporation Investors Should Review Important Updates

Updated Category News Views 193

Key Developments for Unisys Corporation Investors Unisys Corporation (NYSE: UIS) is currently at the center of an important investigation regarding potential securities claims. The Rosen Law Firm, a prominent entity in investor rights, is taking proactive steps to understand the impact of potentially misleading business information on shareholders. Investors should pay...

Continue Reading